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Abstract DNA ligase I (LigI) plays a central role in the
joining of strand interruptions during replication and repair.
In our current study, we provide evidence that DNA ligase
III (LigIII) and XRCC1, which form a complex that
functions in single-strand break repair, are required for the
proliferation of mammalian LigI-depleted cells. We show
from our data that in cells with either dysfunctional LigI
activity or depleted of this enzyme, both LigIII and
XRCC1 are retained on the chromatin and accumulate at
replication foci. We also demonstrate that the LigI and
LigIII proteins cooperate to inhibit sister chromatid
exchanges but that only LigI prevents telomere sister
fusions. Taken together, these results suggest that in cells
with dysfunctional LigI, LigIII contributes to the ligation of
replication intermediates but not to the prevention of
telomeric instability.
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Introduction
Rapid and appropriate rejoining of single-strand breaks
(SSBs) in the DNA duplex is critical to the preservation of
genomic integrity [1–7]. The repair of DNA SSBs involves
lesion detection, processing, gap filling, and ligation (for
reviews see [8–10]). Single-strand break junction defects in
patients are associated with the development of neurode-
generative syndromes [11–13] and cancer predisposition [3].
Patients with DNA ligation defects show greater sensitivity
to DNA-damaging agents and also immunodeficiency [6].
Single-strand discontinuity in the DNA backbone is formed
at the replication fork during lagging strand DNA synthesis
and is transiently introduced by the action of topoisomerases
during replication or transcription to release DNA topolog-
ical constraints. In addition, SSBs are one of the
intermediates of several DNA repair pathways that require
nucleotide replacement and are also formed directly fol-
lowing exposure to ionizing radiation.
In eukaryotic cells, the sealing of SSBs requires the
formation of covalent phosphodiester bonds between
adjacent 50 phosphoryl and 30 hydroxyl groups in the DNA,
a reaction catalyzed by DNA ligases I and III (LigI and
LigIII). Both ligases contain a conserved catalytic domain
flanked by distinct N- and C-terminal regions, which
probably confer some functional specificity [14, 15]. Lig-
aseI interacts with its partner PCNA via the PCNA-binding
motif located in its N-terminus. This interaction directs the
end-joining activity of LigI to Okazaki fragment junctions
on the lagging strand during S phase [16]. In addition, LigI
activity is also involved in DNA joining in the long patch
sub-pathway during base excision repair (BER) [17] and
during double-strand break (DSB) repair by homologous
recombination [18]. The LigIII/XRCC1 complex is a
component of the SSB repair and short-patch BER sub-
pathway [8–10]. In both pathways, the LigIII and XRCC1
interactions that occur through the C-terminal BRCT
domains present on both proteins contribute to LigIII
recruitment [19]. XRCC1-independent functions for LigIII
during alternative non-homologous end-joining (NHEJ)
and in the maintenance of mitochondrial integrity have also
been recently described [20–22].
To date, only one patient (mutation 46Br) has been
identified with a reduction in LigI activity. This arose from
a missense mutation in the LIGI gene that caused an
arginine to tryptophan substitution at amino acid 771 [23].
Expression of the LigI 771Trp mutant in human cells [23–
25] or the equivalent mutant in mouse [26] has been found
to be associated with a delay in the maturation of newly
synthesized Okazaki fragments and a higher rate of sister
chromatid exchange (SCE) compared to wild-type LigI
cells [5, 6, 26, 27]. LigaseI function has been further shown
to be essential in yeast [28], mammalian cells [29], and also
during the early stages of animal development [5, 30].
Nevertheless, mouse embryonic fibroblast cell lines
derived from LIGI-/- animals, although viable, proliferate
with an increased doubling time compared to LIGI?/? cells
[5, 6, 26, 30]. In addition, because 46Br human cells and
LIGI-/- mouse cells are hypersensitive to 3-amino benz-
amide [5, 31], a poly (ADP-ribose) polymerase 1 (PARP-1)
inhibitor, and as PARP-1 plays a role in the recruitment of
the LigIII/XRCC1 complex to SSBs, it has been proposed
that LigIII may partially compensate for the LigI defect in
proliferating 46Br cells.
We show here that LigIII and its partner protein XRCC1
are required to promote the viability of mammalian LigI-
deficient cells and that LigI and LigIII have overlapping
functions in the maintenance of genome integrity. Inter-
estingly, whereas LigI and LigIII cooperate to inhibit SCE,
the depletion of LigI but not LigIII induces sister telomere
fusion, providing evidence for the importance of LigI for
telomere stability.
Materials and methods
Cell lines and shRNA-depleted cell populations
The mouse embryonic fibroblast cell lines derived from
LIGI?/? and LIGI-/- animals were obtained from Dr.
Melton [5, 30]. The human simian virus 40-transformed
fibroblastic lines 46Br.1G1 (European Collection of Cell
Culture) derived from a patient with a LigI deficiency
syndrome [23] and AS3WT2 cells derived from a healthy
donor [32] were maintained in monolayer cultures in
Dulbecco’s modified Eagle’s medium (DMEM) supple-
mented with 15 % fetal bovine serum, and 20 % Medium
199 (Invitrogen). The HeLa, MCF7, U2OS, and HeLa
H2B-GFP [33] lines were maintained in DMEM supple-
mented with 10 % fetal bovine serum. The culture media
for all cell lines contained 200 U/ml penicillin, 200 lg/ml
streptomycin, 1 mM sodium pyruvate, and 4 mM L-gluta-
mine. To obtain cell populations in which specific genes
were suppressed, HeLa and HeLa H2B-GFP cells were
transfected with pEBV vectors expressing an shRNA that
targeted LIGI, LIGIII, XRCC1, or PARP1 [34]. The trans-
fection reagent used was Lipofectamine 2000 (Invitrogen)
and cells were selected in standard media supplemented
with 250 lg/ml hygromycin B (Invitrogen). When indi-
cated, MCF7, U2OS, and HeLa cells were infected for 24 h
by lentiviral particles encoding LIGI shRNA. Transduced
cells were selected for 3 days in media supplemented with
puromycin at a final concentration of 1.5 lg/ml. For dual
shRNA expression, HeLa cells previously transfected with
the indicated pEBV vectors, were infected by lentiviral
particles encoding LIGI shRNA.
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shRNA plasmids
shRNA sequences were designed as previously described
[34]. Two sequences targeting LIGI (NM_000234) at
nucleotides 794–812 and 2,693–2,711 were used and
showed an identical depletion efficiency. The target
sequences were nucleotides 164–182 for LIGIII
(NM_13975), 2,068–2,086 for PARP1 (NM_001618) and
1,832–1,850 for XRCC1 (NM_006297) as previously
characterized [34, 35]. An shRNA sequence targeting the
Luciferase2 gene at the coding sequence 50-CCTACGCC-
GAGTACTTCGA-30 was used as a control. The double-
stranded oligonucleotides were cloned in front of the H1
promoter in the pEBV vector carrying a hygromycin B
resistance cassette.
The lentiviral plasmid pTRIPD3U-MND-EGFP-PURO
was constructed by replacing the NcoI-EGFP-KpnI frag-
ment from the pTRIPD3U-MND-EGFP plasmid [36] with
the NcoI-EGFP-puromycin-KpnI fragment from the pEG-
FP-puromycin plasmid [37]. This conferred enhanced green
fluorescence expression and puromycin resistance. The
H1-shRNA fragments amplified from pEBV-H1-shRNA
by PCR were cloned into the pTRIPD3U-MND-EGFP-
puromycin plasmid. Lentiviral particles were produced as
previously described [36].
Colony formation assay
Cell populations expressing an shRNA from the pEBV
episomal plasmid were trypsinized, counted, and plated at a
low density to facilitate the formation of isolated colonies.
For the HeLa cell populations expressing two shRNAs, the
cells were first transfected with episomal plasmids
expressing either a control shRNA, or LIGIII or XRCC1 or
PARP1 targeting shRNAs. After 7 days of selection with
hygromycin, the HeLaCTL, LigIIIKD, XRCC1KD, and
PARP1KD populations were transduced for 24 h with len-
tiviral particles to introduce either the control or LIGI
shRNA. The transduced cells were trypsinized, counted,
and plated and 24 h later were placed under a combined
puromycin and hygromycin selection. For single or double
shRNA expression, the colonies were fixed after
10–15 days, and stained with Coomassie blue. Colonies of
more than 50 cells were counted.
Preparation of cell lysates and Western blotting
Triton-insoluble fractions were isolated from cells as
previously described [38] with slight modifications.
Briefly, adherent cells from a 60-mm dish were rinsed in
cold PBS and incubated for 10 min on ice with gentle
shaking in 2 ml of buffer A (100 mM NaCl, 300 mM
sucrose, 3 mM MgCl2, 10 mM Pipes pH 6.8, 1 mM
EGTA, Triton X-100) supplemented with protease inhib-
itors cocktail 1 (Sigma-Aldrich). The Triton concentration
used is indicated in Fig. 3. After the removal of buffer A
and rinsing in PBS, adhering cellular material (Triton-
insoluble fraction) was harvested by scraping the cells off
the dishes into PBS. The pellet was resuspended in 60 ll
buffer B (50 mM Tris–HCl, pH 7.5, 20 mM NaCl, 0.1 %
SDS) containing 25 U of the DNase Benzonase (Nova-
gen) and protease inhibitors cocktail 1 (Sigma) and
incubated at room temperature for 10 min. For the prep-
aration of total cell extracts, the cells were rinsed in cold
PBS and harvested by scraping into PBS. The cell pellets
were resuspended in 120 ll of buffer B. Laemmli buffer
was added to these extracts for immunoblotting analysis
with the following primary mouse antibodies: anti-LigI
(5H5) (MBL), anti-LigIII (IF3) (GenTex, Inc.), anti-
XRCC1 (33-2-5) (Abcam), PARP-1 (a gift from Dr.
V. Schreiber), anti-Actin (C4) (Lab Vision CO), and anti-
HP1a (1G9) (Euromedex).
Immunofluorescence microscopy
For the immunofluorescent staining of LigIII or XRCC1
in S phase cells, cells grown on glass coverslips were
incubated in 10 lM BrdU (Becton-Dickinson) for 30 min.
The cells were then fixed in 4 % paraformaldehyde for
5 min at room temperature (RT), rinsed in PBS, and
incubated with 100 % methanol for 10 min at -20 C.
The fixed cells were rinsed once in buffer C [100 mM
Tris–HCl (pH 7.5), 400 mM NaCl, 0.2 % Triton X-100
and protease inhibitors] for 10 min at RT and three times
in TNT buffer [100 mM Tris–HCl (pH 7.5), 150 mM
NaCl, 0.05 % Tween 20]. Cells were then incubated with
PBS complemented with 2 % bovine serum albumin
fraction V (BSA) (Sigma-Aldrich) for 30 min at RT, prior
to incubation with anti-LigIII (BD Biosciences), or anti-
XRCC1 (clone 33-2-5) (Abcam) antibodies at a 1:250 or
1:100 dilution, respectively, in 2 % BSA-PBS for 1 h at
RT. This was followed by incubation with an anti-mouse
antibody coupled to Alexa Fluor 594 (Molecular Probes).
For BrdU staining, the DNA was denatured by incubat-
ing the cells in 4 N HCl for 20 min at RT and the
staining was performed with fluorescein isothiocya-
nate (FITC)-conjugated anti-bromodeoxyuridine (BrdU)
(Becton-Dickinson) in accordance with the manufacturer’s
recommendations. For PCNA staining, the cells were
incubated with FITC-conjugated anti-PCNA (clone PC10;
Chemicon International) at a 1:100 dilution in 2 % BSA-
PBS. For the analysis of LigI and PCNA, or for BrdU
costaining, cells were fixed with cold methanol and
incubated in anti-LigI (clone 5H5; MBL) antibodies at a
1:1,000 dilution in 2 % BSA-PBS. Cells were processed
as described above for BrdU or PCNA detection. Nuclear
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DNA was counterstained with 1 lg/ml 40,60-diamidino-2-
phenylindole (DAPI). Coverslips were mounted in Dako
Fluorescent Mounting Medium. Image acquisition was
performed with a Leica confocal microscope SPE
(Wetzlar, Germany), using an ACS APO 63.0 9 1.30 oil
lens or a Leica DM5500 equipped with a CoolSNAP HQ
CCD camera using an HCX PL S—APO 63/1.30 oil lens.
The images from mid- and late-S phase cells were pro-
cessed with ImageJ software (http://rsbweb.nih.gov/ij/).
The images from each channel were binarized and we
applied a threshold filter in order to remove the back-
ground. The images were processed with a colocalization
threshold filter to obtain a merge binary image from
which non-overlapping pixels were removed. The result-
ing black-and-white images (labeled thresholded images)
were used to determine the percentage of nuclei with
more than two late-replication structures (ring- or horse-
shoe-shape staining). For each double-staining
combination, more than 40 nuclei were analyzed per cell
line.
Sister chromatid exchanges (SCE)
To analyze SCE, cells were cultured in complete medium
supplemented with 10 lM BrdU for two cell cycles. After
the addition of colchicine at 10 lg/ml for 2 h, the cells
were collected and incubated in KCl (0.075 M) and human
serum (1:6 v/v) for 20 min at 37 C, fixed in ethanol/acetic
acid (3:1 v/v), and spread on cold and clean slides. The
slides were incubated in Hoechst (33258) dye at 50 lg/ml
for 20 min and then denatured by exposure to ultraviolet
(UV) light at 365 nm (Fisher Bioblock Scientific) for
30 min in the presence of 2 9 SSC. After washing in bi-
distilled water, the slides were further stained with 1.5 %
Giemsa and 1.5 % phosphate buffer in bi-distilled water.
Metaphases were observed under a microscope (Olympus
AX70) and analyzed using the Cytovision system. The
SCE frequency was calculated as the total number of SCEs
divided by the total number of chromosomes.
Telomere-fluorescent in situ hybridization (Telo-FISH)
Telomere-fluorescent in situ hybridization was performed
using a Cy-3-labeled (CCCTAA)3 PNA probe (Applied
Biosystems) which is specific for the G-rich telomeric
strand. Labeling of metaphase spreads was carried out as
previously described [32]. The chromosome preparations
were then counterstained with DAPI and observed under a
fluorescence microscope (Olympus AX70). Digital images
were recorded using a camera JAI and analyzed with the
Cytovision system. Sister telomere fusions in at least 35
metaphases were scored and statistical analyses were per-
formed with StatView software.
Chromosome orientation-FISH (CO-FISH)
Chromosome orientation-FISH was performed as previ-
ously described [32, 39–41]. Briefly, cells were cultured in
complete medium supplemented with 10 lM BrdU for one
cell cycle. Metaphase spreads obtained as described above
were stained with Hoechst 33258 and then exposed to UV
light and digested with exonuclease III (Promega) to
remove newly synthesized DNA strands. Successive
hybridizations with FITC-labeled (TTAGGG)3 PNA probe
(Applied Biosystems), then with a Cy-3-labeled
(CCCTAA)3 PNA probe allowed the detection, by fluo-
rescence microcopy, of parental telomere strains whereby
telomeric lagging strands are stained in red and telomeric
leading strands are stained in green.
Live videomicroscopy
Cells were grown on poly-D-lysine coated glass coverslips.
Prior to acquisition, glass coverslips were mounted in a
Ludin Chamber (Life Imaging Services). Live microscopy
was then carried out using an inverted microscope
(Olympus IX81) placed in an incubator chamber (Life
Imaging Services) maintained at 37 C, and coupled with a
CoolSNAP HQ camera (Princeton Instruments) controlled
by Metamorph software (Universal Imaging) as previously
described [41]. The fluorescent GFP images were captured
on 10–20 fields using a 209 objective (LCPFI, NA 0.40,
Olympus) every 2 min for 10 h. Movies were processed
with Metamorph software.
Results
DNA ligase III and XRCC1 localize at replication foci
in DNA ligase I-deficient cells
We investigated the nuclear distribution of endogenous
LigI, LigIII, and XRCC1 proteins in the nuclei of LIGI?/?
and LIGI-/- mouse embryonic fibroblasts cell lines. The S
phase cells were identified through the characteristic
immunostaining patterns of either incorporated BrdU [42,
43] or chromatin-bound PCNA foci [44, 45]. The BrdU- or
PCNA-positive nuclei were categorized into early, mid-, or
late-S subgroups based on the characteristic replication
patterns. Early S phase nuclei are characterized by a pattern
of high density of small BrdU or chromatin-bound PCNA
foci spread throughout the nucleus, and mid- or late-S
phase mouse cells have a typical ring-shape BrdU and
PCNA staining around heterochromatin domains [43]. As
expected, endogenous LigI protein was not detectable in
LIGI-/- cells and co-localized at BrdU stained DNA rep-
lication foci in LIGI?/? cells (Fig. 1a) [46]. The
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immunostaining of endogenous LigIII protein in the nuclei
of non-S phase and early S phase LIGI?/? cells appeared to
be evenly distributed with no obvious co-localization with
BrdU or PCNA foci (electronic supplementary material,
ESM Fig. 1a). However, within the mid- or late-S-phase
LIGI-/- population, we could easily observe distinct and
intense LigIII (Fig. 1b) and XRCC1 (Fig. 1 and ESM
Fig. 1b) foci in a mostly diffuse staining pattern, these foci
strongly co-localizing to mid- or late-S-phase ring-shaped
BrdU or PCNA foci. Merged images from mid- or late-S-
phase cells co-immunostained for BrdU and either LigIII
(Fig. 1b) or XRCC1 (ESM Fig. 1b), or from cells co-
immunostained for LigIII or XRCC1 and PCNA (Fig. 1b
and ESM Fig. 1c) were thresholded. The resulting thres-
holded images were then used to determine the percentage
of nuclei with more than one co-stained mid- or late-S-
phase ring-shaped focus under each set of experimental
conditions. The percentage of cells with mid- and late-S-
phase replication foci co-stained for LigIII/BrdU or LigIII/













Fig. 1 Mouse LigI-deficient cells show endogenous LigIII and
XRCC1 accumulation at PCNA- and BrdU-stained foci. a Endogenous
LigI (red) was co-immunodetected with BrdU incorporation sites
(green) in proliferating wild-type (LIGI?/?) and LIGI knockout
(LIGI-/-) mouse cells. b Co-immunodetection of endogenous LigIII
(red) and BrdU incorporation site or PCNA staining (green) in late-S
phase LIGI?/? and LIGI-/- cells. LigIII signal overlapping with
BrdU or PCNA signal is observed in LIGI-/- cells with typical late-S
phase BrdU or PCNA staining (enlarged images below showing
examples of late-replication structures ring-shape or horseshoe
staining). The thresholded images were obtained as described in
‘‘Materials and methods’’. Scale bars 5 lm. c Percentages of nuclei
with more than two late-replication structures in the depleted cells.
For each double staining combination, more than 40 nuclei were
analyzed per cell line. Representative images from cells co-immuno-
stained for endogenous XRCC1 and BrdU or XRCC1 and PCNA are
presented in ESM Fig. 1b, c
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LIGI?/? cells to 89.7 and 89 % in LIGI-/- cells (Fig. 1c).
In addition, the percentage of cells with mid- or late-S-
phase replication foci co-stained for XRCC1/BrdU or
XRCC1/PCNA (Fig. 1c and ESM Fig. 1b, and c), signifi-
cantly increased from 1.3 to 4.3 % in the LIGI?/? cells to
68.5 and 72.3 % in LIGI-/- cells (Fig. 1c). These obser-
vations suggest that a complex containing the LigIII/
XRCC1 DNA repair proteins accumulates at mid- and late-
S-phase DNA replication sites in LigI-deficient proliferat-
ing mouse cells.
Comparison of the human fibroblastic line 46Br.1G1
derived from a patient with a LigI-deficiency syndrome
with a control AS3WT2 line derived from a healthy donor
also demonstrated a significant increase in the co-locali-
zation of either LigIII or XRCC1 with either BrdU
(Fig. 2a) or PCNA foci (ESM Fig. 2). The percentage of
cells with mid- and late-S-phase replication foci co-stained
for LigIII/BrdU or LigIII/PCNA was, respectively, 22 and
27.5 % in AS3WT2 cell line compared to 88.5 and 87.5 %
in 46Br.1G1 cell line (Fig. 2c and ESM Fig. 2), and the
percentage of nuclei with co-stained for XRCC1/BrdU S
phase replication foci was 25.5 % in the AS3WT2 cell line
and 69 % in 46Br.1G1 cell line (Fig. 2c).
In order to analyze LigI depletion in the same genetic
background, we used HeLa cells to target LigI or LigIII
expression by introducing shRNA vectors. We transfected
an episomal plasmid to generate a HeLaCTL control cell
line expressing a control shRNA, and HeLa LigIKD and
LigIIIKD line expressing an shRNA targeting LIGI or
LIGIII, respectively [34]. Western blots are presented in
Fig. 3b. We observed that in the HeLa LigIKD cells, Li-
gIII immunostaining was mostly diffuse with distinct and
intense foci in mid- and late-S-phase cells, while no Li-
gIII staining was observed in the HeLa LigIIIKD cells
(Fig. 2b). Depletion of the LigI protein in proliferating
HeLa LigIKD cells was found to be associated with an
increase in the percentage of nuclei with co-stained for
LigIII/PCNA S phase replication foci from 25.5 % in the
HeLaCTL cell line to 61 % in HeLa LigIKD cell line
(Fig. 2b, c). Taken together, these observations show that
the accumulation of the LigIII and XRCC1 proteins to
BrdU or PCNA foci in proliferating cells is a conserved
response to a LigI deficiency between mouse and human
cell lines.
DNA ligase III and XRCC1 proteins are recruited
to chromatin in DNA ligase I-deficient cells
It has been shown that the LigIII/XRCC1 complexes
localized at DNA damage sites are resistant to detergent
extraction [47–49]. To assess if the XRCC1 and LigIII
proteins were tightly bound to the nuclear fraction in pro-
liferating LigI-deficient cell lines, we treated HeLaCTL and
HeLa LigIKD cell lines with Triton X-100-containing buf-
fers to extract the soluble fraction and analyzed the
insoluble chromatin and/or nuclear matrix fraction for its
LigIII and XRCC1 content by Western blotting. We found
that the LigIII and XRCC1 proteins were efficiently
extracted from HeLaCTL cells treated with 0.5 and 1 %
Triton containing buffer. In contrast, under the same
extraction conditions, the LigIII and XRCC1 proteins were
retained in the Triton-resistant fraction from HeLa LigIKD
cells (Fig. 3a). We next analyzed the solubility of the Li-
gIII and XRCC1 proteins from HeLa, MCF7, and U2OS
cells in which an anti-LIGI shRNA was introduced by
lentiviral transduction. Less than 1 % of the total amount
of LigIII or XRCC1 could be detected in the 0.5 % Triton-
resistant fraction from control populations in any of the
three cell types. However, a significant amount of LigIII
and XRCC1 proteins were found to be resistant to deter-
gent extraction in the LigI-depleted populations (Fig. 3b).
Both 46Br.1G1 cells and LIGI-/- mouse cell lines have a
lower level of LigIII protein, however, more LigIII protein
was detected in the insoluble fraction from these cells than
in the respective control lines (Fig. 3c). In conjunction with
the observation of the co-localization of the LigIII and
XRCC1 proteins at replication foci, these results showing a
tight binding of LigIII and XRCC1 to the chromatin sug-
gest a role for the LigIII/XRCC1 complex in the replication
processes in LigI-deficient cells.
The viability of LigI-deficient cells is dependent
on the LigIII, XRCC1, and PARP-1 proteins
We next determined the effect of LigI depletion on the
plating efficiencies of HeLa, MCF7, and U2OS cells
expressing LIGI shRNA via lentiviral transduction. The
resulting HeLa shLigI, MCF7 shLigI, and U2OS shLigI
cells showed reduced colony formation to 60, 54, and 62 %
of the levels found for the respective control shRNA cells
(Fig. 4a, Western blots are presented in Fig. 3b). To
investigate the requirements for LigIII and XRCC1 in
colony formation in the context of a LigI defects in HeLa
cells, we targeted these proteins by expressing shRNAs
(Fig. 4c). Because of the role of the SSB DNA sensor
PARP-1 protein during DNA strand repair, the function of
PARP-1 in colony formation in the context of a LigI defect
in HeLa cells was also analyzed. The plating efficiencies of
the HeLa LigIIIKD, HeLa XRCC1KD, and HeLa PARP-1KD
cell populations were 75, 42, and 35 %, respectively,
compared to HeLaCTL control cells (Fig. 4b). The addi-
tional depletion of LigI in these cells by the introduction of
a LIGI targeting shRNA via lentiviral transduction reduced
the plating efficiency of all the populations to less than 4 %
of the controls at 15 days post-infection (Fig. 4b). In
addition to confirming the requirement of the PARP-1 for
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the viability of LigI-deficient cells [5, 25, 50], these results
show that the repair proteins LigIII and XRCC1 are also
required for the viability of LigI-impaired cells.
Furthermore, we compared the DNA replication effi-
ciency by a BrdU incorporation assay 2 days post-
depletion in single-DNA ligase depleted cell populations
46Br.1G1AS3WT2








LigI BrdU merge LigI BrdU merge
XRCC1 BrdU merge
LigIII BrdU merge C
Fig. 2 LigIII and XRCC1 proteins accumulate at PCNA and BrdU-
stained foci in the 46Br.1G1 cells derived from a LigI-deficient
patient or in human cells depleted in LigI by shRNA targeting.
a Detection of endogenous LigIII, XRCC1 or LigI (in red) and BrdU
incorporation sites (green) in AS3WT2 human cells derived from a
healthy donor and 46Br.1G1 cells obtained from a LigI-deficient
patient. Co-localization of the LigIII, XRCC1 or LigI proteins and the
BrdU-positive replication foci appears as yellow spots in the merged
images. b Endogenous LigIII (red) and PCNA foci (green) in control
HeLa cells (HeLaCTL), LigI-depleted HeLa cells (HeLa LigIKD) or
LigIII-depleted HeLa cells (HeLa LigIIIKD). The co-localization of
LigIII protein and PCNA foci appears as yellow spots in the merged
images. Scale bar on all merged images, 5 lm. c Thresholded merge
images were used to determine the percentage of nuclei from
AS3WT2 and 46Br.1G1 cells lines (left panel) and from HeLaCTL and
HeLa LigIKD cell lines (right panel) with more than two typical mid-
or late-replication structures are presented for the indicated co-
staining
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(HeLa LigIIIKD and HeLa CTL-shLigI) and double-DNA
ligase depleted cell populations (HeLa LigIIIKD-shLigI)
(Fig. 4c, d, e). The percentages of BrdU-positive cells were
similar in the single-LigI and LigIII-depleted populations
(42 % in HeLa CTL-shLigI compared to 46.5 % in HeLa
LigIIIKD-shLigI). However, the percentage of BrdU-posi-
tive cells was dramatically reduced in HeLa LigIIIKD-
shLigI cells (5.5 %). These results suggest that the reduced
viability of cells depleted for both LigI and LigIII results
from a defect in the replication process.
LigI and LigIII cooperate to prevent SCEs
One of the hallmarks of 46Br.1G1 cells [5, 6] and LigIII
deficiency in mouse cells [7] is the increase in the incidence
of SCEs. The percentages of SCEs per chromosome (SCE
Fig. 3 Increase in chromatin-




expressing control, LIGI, or
LIGIII shRNAs from the pEBV
episomal plasmid were
harvested and divided into two
fractions: whole cell extracts
(WCE) and extracts prepared
with the indicated Triton
concentrations to yield the
insoluble fraction. The WCE
preparation (left panel) and
Triton-resistant extracts (right
panel) were then analyzed by
Western blotting with the
indicated antibodies. *Non-
specific band. b WCE (left
panel) and the 0.5 % Triton-
resistant extracts (right panel)
were also prepared from
lentiviral-transduced HeLa,
MCF7, and U2OS cell
populations expressing the
indicated shRNA and then
analyzed by Western blotting
with the indicated antibodies.
c WCE (left panel) and 0.5 %
Triton-resistant (right panel)
LIGI?/? and LIGI-/- mouse
cell line and AS3WT2 and
46Br.1G1 human cell line
extracts analyzed by Western
blotting with the indicated
antibodies
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frequency) in metaphase spreads from HeLa, MCF7, and
U2OS cells transduced with an LIGI shRNA were deter-
mined. An increase in the SCE frequency of 1.9-, 1.5-, and
1.4-fold, respectively, (p \ 0.0001) in the HeLa, MCF7, and
U2OS LigI-depleted cells compared to their corresponding
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level was not affected upon LigI depletion in these cell lines
(Fig. 3b). To analyze the impact of both LigI and LigIII
depletion on the SCE frequency, HeLaCTL or HeLa LigIIIKD
cell lines were transduced either with a control or LIGI tar-
geting shRNA-producing HeLaCTL-shCTL, HeLa LigIIIKD-
shCTL, HeLaCTL-shLigI and HeLa LigIIIKD-shLigI cell
populations. A similar XRCC1 protein level was observed in
HeLa cells depleted for LigI or LigIII or in both LigI and
LigIII-depleted cells (Fig. 4c). The SCE frequencies in these
cells were then measured at 3 days post-transduction, an
early time point where a fraction of HeLa LigIIIKD-shLigI
cells was still dividing. When compared to HeLaCTL-shCTL
cells, the SCE frequencies in the HeLaCTL-shLigI cells and
HeLa LigIIIKD-shCTL cells were increased by 1.9-fold
(p \ 0.0001) and 1.5-fold, respectively (p \ 0.0001)
(Fig. 5). The observed SCE frequencies in the HeLaCTL-
shLigI (0.326 % SCEs) and HeLa LigIIIKD-shCTL (0.257 %
SCEs) cells were also significantly different (p \ 0.0001)
(Fig. 5). In cells depleted for both LigIII and LigI (HeLa
LigIIIKD-shLigI) cells, the SCE frequency was 1.26 %,
which is a striking increase compared to the HeLaCTL-shCTL
cells (7.5-fold, p \ 0.0001), HeLaCTL-shLigI cells (5.2-fold,
p \ 0.0001) or the HeLa LigIIIKD-shCTL cells (4.8-fold,
p \ 0.0001) (Fig. 5). Based on this observed synergistic
increase in SCEs in the LigI–LigIII-depleted cells, we
speculate that LigI and LigIII can complement each other in
the suppression of SCEs.
The depletion of LigI but not LigIII induces sister
telomere fusion
The consequences of LigI depletion on telomere stability
were next investigated by Telo-FISH staining of
Table 1 The SCE frequency increases in cells depleted of LigI by
lentiviral transduction
Cell line SCEa pb nc
HeLa shCTL 0.169 ± 0.010 43 (2,839)
HeLa shLigI 0.326 ± 0.021 \0.0001 51 (3,370)
MCF7 shCTL 0.194 ± 0.009 40 (2,739)
MCF7 shLigI 0.281 ± 0.016 \0.0001 40 (2,728)
U2OS shCTL 0.141 ± 0.008 43 (3,184)
U2OS shLigI 0.216 ± 0.042 \0.0001 38 (2,776)
a Equals the total number of sister chromatid exchanges divided by
the total number of chromosomes counted; ± indicates the 95 %
confidence interval
b Determined via the Mann–Whitney test
c Number of metaphase spreads from which the SCE frequency was
determined; the values in parentheses indicate the total number of
chromosomes analyzed in each lentiviral-transduced cell population
Fig. 5 LigI and LigIII
cooperate in the suppression of
SCEs. A representative image of
metaphase spreads prepared for
SCE analysis from HeLa cells
depleted in both LigI and LigIII.
The histogram on the left shows
the average SCE frequency per
chromosome in the different cell
types calculated from 37 to 50
metaphases for each cell lines
***p \ 0.0001
Fig. 4 LigIII is required for the viability and efficient DNA
replication of the LigI-deficient cells. a Effects of LigI-depletion on
the plating efficiency in HeLa, MCF7, and U2OS cells following
lentiviral transduction with a LIGI shRNA (shLigI) were compared to
the respective control (shCTL) cell populations. b The control shRNA
(shCTL) or LIGI shRNA (shLigI) molecules were introduced by
lentiviral transduction of HeLa cells expressing either a control
(CTL), LIGIII (LigIIIKD), XRCC1 (XRCC1KD), or PARP1
(PARP1KD) shRNA from the pEBV episomal plasmid. The plating
efficiency of the cell populations expressing the indicated pair of
shRNAs was compared to that of the HeLaCTL-shCTL cells express-
ing the control shRNAs. c The LigI, LigIII, XRCC1, and PARP1
protein levels were analyzed by Western blotting. d Two days post-
infection, LigI-depletion was verified at the cellular level by
immunofluorescence (red) and the replicating cells were detected
by BrdU incorporation (green). e Percentages of BrdU-positive cells
detected in the indicated HeLa cells populations following a 30-min
BrdU pulse. The values ± SD represent the mean of two experiments
for which at least 150 nuclei per experiment were scored
b
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chromosomes from the telomerase-positive cell line MCF7
and the U2OS cell line. In both lines, an increase in the
percentage of chromosomes with sister telomere fusions
was observed when LigI was depleted by lentiviral trans-
duction (0.3 % in U2OS shCTL and 1.2 % in U2OS shLigI
cells, p = 0.002; 0.5 % in MCF7 shCTL, and 1.4 % in
MCF7 shLigI cells, p = 0.03; Fig. 6a). We also compared
these rates in HeLa cells depleted in LigIII, LigI, or both
DNA ligases. A sister telomere fusion rate of 1.4 % in the
HeLaCTL-shLigI cells, which represents a 2.8-fold
(p = 0.004) and twofold (p = 0.004) increase compared to
HeLaCTL-shCTL and HeLa LigIIIKD-shCTL cells, respec-
tively, was observed (Fig. 6b). The percentages of
chromosomes with sister telomere fusions in HeLa LigI-
IIKD-shCTL and HeLaCTL-shCTL cells were not
significantly different (p = 0.4). However, 1.7 % of chro-
mosomes exhibited sister telomere fusions in the HeLa
LigIIIKD-shLigI cells depleted for both ligases, which is a
significant increase compared with HeLaCTL-shCTL
(p \ 0.0001) and HeLa LigIIIKD-shCTL (p \ 0.002) cells.
Interestingly, the HeLaCTL-shLigI and the HeLa LigIIIKD-
shLigI cells showed a similar rate of sister telomere fusions
(p = 0.4). Hence, a defect in LigI but not in LigIII was
found to be associated with an increased occurrence of
sister telomere fusions.
We next performed CO-FISH, which allows the identi-
fication of newly replicated lagging (stained in red) and
leading (stained in green) strand telomeres of metaphasic
chromosomes [39]. This analysis confirmed the presence of
both lagging and leading strand telomeres at fused sister
chromatids in the HeLaCTL-shLigI and the HeLa LigIIIKD-
shLigI cells (Fig. 6c). Chromosome orientation-FISH did
not, however, reveal the induction of reciprocal sister
telomere exchange (T-SCE) in HeLa cells depleted of LigI
or LigIII, either individually or together. In contrast, we
found a significant increase in non-reciprocal telomeric
strand exchanges in HeLa LigIIIKD-shLigI cells (1.8 % of
chromosomes vs. less than 0.2 % in the other cell types
tested). Non-reciprocal telomeric strand exchanges were







































































































































































Fig. 6 Telomere instability in LigI-depleted HeLa cells. a Percent-
ages (mean ± SD) of sister telomere fusions per chromosome
determined from Telo-FISH-stained metaphase spreads of the indi-
cated transduced cells and an example of a chromosome with a sister
telomere fusion (white arrow). b Percentages of chromosomes with
sister telomere fusion determined from Telo-FISH-stained metaphase
spreads for the indicated cell populations. c Example of sister
telomere fusion (yellow, white arrow) involving both leading (green)
and lagging (red) strand telomeres. d Percentage of chromosomes
with lagging strand telomere capture in the different cells indicated
(left) and example of lagging strand telomere capture detected by CO-
FISH (white arrow). e Percentage of chromosomes with leading
strand telomere capture in the different cells indicated (left) and
example of leading strand telomere capture detected by CO-FISH
(white arrow). Percentages were calculated from 32–42 metaphases
for each cell line. Statistical significance levels are noted as follows:
***p \ 0.0005, **p \ 0.005, and *p \ 0.05
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DNA in the lagging strand telomeres (referred to as leading
strand telomere capture; Fig. 6d) or by the presence of
telomere lagging strand DNA in the leading strand telo-
meres (referred to as lagging strand telomere capture;
Fig. 6e) resulting in yellow staining at the telomeres.
Interestingly, the HeLa LigIIIKD-shLigI cells exhibited the
most lagging strand telomere captures. Taken together,
these data suggest that LigI defects induce telomere
instability as a consequence of DNA breaks in the lagging
strand telomeres, which result in subsequent sister telomere
fusion, and are not prevented by LigIII. However, the
lagging strand telomere captures in HeLa LigIIIKD-shLigI
cells are likely to be the consequence of additional breaks
within lagging strand telomeric DNA. Hence, their absence
in HeLaCTL-shLigI cells, in contrast to HeLa LigIIIKD-
shLigI cells, indicates that LigIII partially compensates for
the LigI defect and thereby reduces some of the lagging
strand telomere instability.
The depletion of LigI increases the incidence of mitotic
abnormalities
We next followed the progression of mitosis in HeLa H2B-
GFPCTL and HeLa H2B-GFP LigIKD cells through live
microscopy (Fig. 7a, b and ESM video 1, 2 and 3). The
depletion of LigI in HeLa H2B-GFP cells via an episomal
plasmid dramatically increased the incidence of abnormal
mitoses (37.6 % of the mitoses in HeLa H2B-GFP LigIKD
cells compared to only 5 % in the HeLa H2B-GFPCTL
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Fig. 7 LigI-defect promotes an increased number of mitotic abnor-
malities. a Representative time-lapse images of HeLa H2B-GFP
LigIKD mitosis. The videos of these mitotic events were synchronized
from the onset of prophase. The numbers indicate the time in minutes,
the arrows point to bridged DNA (middle row) and misaligned
chromosomes (lower row). b Percentage of mitoses in control (open
bar) and LigIKD HeLa H2B-GFP (closed bar). c Percentage of
abnormal mitoses in control and LigIKD HeLa H2B-GFP. d Percentage
of abnormal mitoses with anaphase bridges. e Percentage of abnormal
mitoses with misaligned chromosomes. A total of 257 and 270
mitoses were analyzed, respectively. Statistical significance levels are
noted as follows: NS not significant, *p \ 0.02 and (***p \ 0.0001)
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mainly due to anaphase bridges (23.8 % of mitoses in
HeLa H2B-GFP LigIKD cells compared to 2.3 % in HeLa
H2B-GFPCTL; p = 0.0001) (Fig. 7d and ESM video 2) and
misaligned chromosomes (10.5 % of mitoses in HeLa
H2B-GFP LigIKD compared with 0.8 % in HeLa H2B-
GFPCTL; p = 0.08) (Fig. 7e and ESM video 3). These
mitotic abnormalities through the onset of chromosome
misalignments and anaphase bridges were most probably
initiated as the cells progressed through mitosis with sister
telomere fusions resulting from the LigI defect. Hence, our
results suggest that a reduction in viability of LigI-deficient
cells is at least partially due to sister telomere fusions
resulting from lagging strand telomere instability and
therefore that LigIII cannot functionally compensate for the
loss of LigI in this regard.
Discussion
We have shown here that in mammalian LigI-deficient
cells, LigIII and XRCC1 are retained on chromatin at
replication foci and that both proteins are required for
the long-term survival of these cells. We further show
for the first time that both LigI and LigIII cooperate to
suppress SCEs, but that LigIII is not sufficient to pre-
vent sister telomere fusions in LigI-deficient cells,
revealing the importance of LigI function in telomere
stability.
The proliferation of mouse embryonic fibroblast cell
lines derived from LIGI-/- animals [5, 6, 26, 30] indicates
that alternative pathways can compensate for this defect
and contribute to cell viability. LigaseIII, like LigI, cata-
lyze the sealing of SSBs. LigaseIII recruitment during
DNA repair onto a ligatable substrate is dependent on its
SSB-binding domain [51] and/or on the nick- and gap-
DNA-binding protein XRCC1 [52, 53]. We have shown
that LigIII and XRCC1 proteins co-localize with replica-
tion sites and become Triton-resistant when LigI function
is compromised (Figs. 1, 2, 3), thus resembling the LigIII/
XRCC1 foci induced by DNA damage [47, 48, 54–56].
Moreover, the viability of LigI-deficient human cells is
dependent on LigIII, XRCC1, and PARP-1 and both LigI
and LigIII are required for efficient DNA replication
(Fig. 4). These observations are consistent with a recent
study reporting that in chicken cells (DT40) LigIII can
efficiently substitute for all major DNA replication func-
tions of LigI [57]. We have also shown that PARP-1 is
required to support the viability of LigI-deficient cells,
which is consistent with previous studies showing that
PARP activity inhibition is deleterious in conjunction with
a LigI defect [5, 25, 50]. Hence, the LigIII/XRCC1 foci
formation during S phase in LigI-deficient cells is likely to
be dependent on PARP-1 activity, which is known to
facilitate the recruitment of LigIII/XRCC1 complex to
single-strand interruptions [10, 58].
The detection of the LigIII and the XRCC1 proteins at/
or close to the replication sites and their requirement for
the viability of LigI-deficient cells strongly suggest that the
XRCC1/LigIII complex contributes to the sealing of lag-
ging strand replication intermediates behind replication
forks in LigI-deficient cells. Previous investigations of the
consequences of a LigI defect have led to conflicting
results. It has been reported that perturbing the function of
the human LigI orthologue in yeast [59], plants [60],
chicken B cell line [57], and mice [26] results in S phase
progression defects compared to their wild-type counter-
parts. In contrast, other studies observed a normal cell
cycle distribution in mice and human LigI-deficient cells
[5, 61]. The 46Br.1G1 cells, which have low LigI activity,
can proliferate despite persisting DNA damage. Soza and
colleagues have suggested that an adaptive response may
underlie the proliferation of these cells [61]. The matura-
tion of newly synthesized Okazaki fragments is delayed in
the 46Br.1G1 cell line and in the LIGI-/- mouse embry-
onic fibroblast cell lines [5, 6, 26, 27]. It has been thus
proposed that another DNA ligase may partially compen-
sate for the LigI defect in these LigI-deficient proliferating
cells [30, 49]. We have shown that the LigIII/XRCC1
proteins are present at/or close to the replication sites in
cells with impaired LigI function (Figs. 1, 2). The repli-
cation defect observed in LigI–LigIII-depleted cells
suggests that the proliferation of LigI-deficient cells may
therefore rely on the recruitment of the LigIII/XRCC1
complex. Of note in this regard, it should be pointed out
that there is no DNA ligase III homolog in yeast and plants,
which could explain why LigI depletion severely affects S
phase progression in these organisms (for review, see [15]).
The interaction of XRCC1 with replication factors [62–
65] and its requirement for a replication fork restart post-
MMS (methyl methanesulfonate) treatment [35, 66–68] has
led to the hypothesis that XRCC1 may be involved in the
coordination of replication-coupled repair. It is therefore
likely that XRCC1, in association with LigIII, could favor
the joining of unligated replication intermediates in LigI-
deficient cells, which is also likely to require PARP-1 [69,
70] possibly through its role in the regulation of replication
fork progression [71]. The replication-coupled SSBR
pathway involving XRCC1 and a number of its known
binding proteins [49, 62, 63, 65] may promote the joining
of SSBs during replication fork progression in LigI-defi-
cient cells, thus allowing S phase progression.
Both the small increase in the spontaneous SCE fre-
quency in LigI- or in LigIII-deficient cells, observed here
(Fig. 5) and previously by others [5–7], and the dramatic
synergistic increase in the frequencies of spontaneous
SCEs in the LigI–LigIII-depleted cells, show that LigI and
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LigIII can efficiently compensate for each other to suppress
SCE. Hence, our present observations support a model in
which the ligation of replication intermediates in LigI-
deficient cells is dependent on the LigIII, albeit with a
delay compared to LigI-proficient cells [5, 6, 26, 27]. This
LigI and LigIII functional redundancy would serve to
prevent the formation of DSBs as the replication forks
progresses towards SSBs, which can otherwise result in the
loss of cell viability and in the formation of SCEs [72].
Partial redundancy between the LigI and LigIII during
DNA repair was shown in vivo and in vitro [73, 74]; it was
observed that in LigIII-deficient mice, the LigI is involved
in translocation formation by alternative NHEJ [20–22]
and previous studies that have analyzed ligation reactions
using in vitro DNA repair assays have shown a partial
overlap in the functions of LigI and LigIII [73, 74].
We further show in our current experiments that LigIII
could not totally prevent telomere instability resulting from
a LigI defect. A defect in lagging-strand processing pro-
teins including polymerase a, the endonuclease FEN-1 and
the helicase/nuclease Dna2 is associated with compromised
telomere functions [75–78]. In mouse cells, a polymerase-a
defect results in the elongation of single-stranded telomeric
G-strand overhangs and in Robertsonian translocations
[75], whereas an FEN-1 defect induces telomere shortening
[77] and telomere end-to-end fusions [76, 77]. To our
knowledge, our present study is the first report showing
that a LigI defect induces sister telomere fusions (Fig. 6).
Both leading- and lagging-strand telomeres are pro-
tected from end-to-end fusions by a specific telomeric
nucleoprotein complex and a DNA architecture that
includes a 30-overhang. Events known to render sister
chromatids prone to fusion by NHEJ after replication [79,
80] include altered sister chromatid dissociation [79] or
impaired formation of the telomere protective conforma-
tion [32, 40, 41]. The remaining SSBs resulting from
compromised Okazaki fragment ligation during telomere
replication in LigI-deficient cells could render the lagging-
strand telomere more prone to DSBs. Broken lagging-
strand telomeres will be fused by NHEJ with the newly
replicated leading chromatid at which the protective
G-strand overhang has not yet been formed [81, 82] and
give rise to the dramatic increase in sister telomere fusions
observed in LigI-deficient cells. We cannot exclude from
our data the possibility that telomere breakage resulting
from impaired SSB repair in LigI-deficient cells can also
contribute to sister telomere fusions.
Although we have demonstrated here that LigIII does
not compensate for the function of LigI that prevents sister
telomere fusions, the low frequency of lagging- or leading-
strand telomere capture in LigI-deficient and LigIII-defi-
cient cells compared with LigI-LigIII-deficient cells clearly
demonstrates that both LigI and LigIII can participate in
the maintenance of telomere stability by preventing telo-
meric strand capture. Lagging-strand telomere capture in
HeLa LigIIIKD-shLigI cells is likely the consequence of
additional breaks within lagging strand telomeric DNA.
Hence, their absence in HeLaCTL-shLigI cells, in contrast
to HeLa LigIIIKD-shLigI cells, indicates that LigIII at least
partially compensates for the LigI defect, thus reducing if
not preventing lagging-strand telomere instability. These
observations are consistent with the role of DNA repair
proteins including PARP-1 and the polymerase-b protein in
the maintenance of telomere integrity [83, 84].
In conclusion, our present observations show that the
LigIII/XRCC1 complex is required to promote the viability
of mammalian LigI-deficient cells and that LigI and LigIII
efficiently cooperate during DNA replication and to inhibit
a high frequency of SCE events. However, LigIII cannot
fully compensate for the loss of LigI function at telomeres,
which results in lagging-strand telomere instability and
sister telomere fusions. This reveals the importance of LigI
for telomere stability.
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